MalVac: Database of malarial vaccine candidates

MalVac: Database of malarial vaccine candidates

<p>Abstract</p> <p>Background</p> <p>The sequencing of genomes of the Plasmodium species causing malaria, offers immense opportunities to aid in the development of new therapeutics and vaccine candidates through Bioinformatics tools and resources.</p> <p>Met...

Full description

Bibliographic Details
Main Authors:	Singh Harinder, Ansari Faraz, Ahmed Shakil, Chaudhuri Rupanjali, Ramachandran Srinivasan
Format:	Article
Language:	English
Published:	BMC 2008-09-01
Series:	Malaria Journal
Online Access:	http://www.malariajournal.com/content/7/1/184

Similar Items

FungalRV: adhesin prediction and immunoinformatics portal for human fungal pathogens
by: Ramachandran Srinivasan, et al.
Published: (2011-04-01)

VACS: VAccination disComfort Scale
by: Manolis Wallace, et al.
Published: (2022-12-01)

Association of humoral immunity status and thrombodynamics after vaccination with Gam-COVID-Vac and CoviVac
by: O. M. Drapkina, et al.
Published: (2022-07-01)

Travel vaccination mapping application (VacMAP)
by: Goh, Chun Yi
Published: (2021)

Genome stability of the vaccine strain VAC∆6
by: R. A. Maksyutov, et al.
Published: (2022-07-01)

Use of VacA as a Vaccine Antigen
by: Mati Moyat, et al.
Published: (2016-06-01)

Mind the gaps - The epidemiology of poor-quality anti-malarials in the malarious world - Analysis of the WorldWide Antimalarial Resistance Network database
by: Tabernero, P, et al.
Published: (2014)

Mind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world--analysis of the WorldWide Antimalarial Resistance Network database.
by: Tabernero, P, et al.
Published: (2014)

A case of resistant malarial infection with hyper reactive malarial splenomegaly
by: P K Singh, et al.
Published: (2015-01-01)

Humoral responses to the CoronoVac vaccine in healthcare workers
by: Gokhan Eyupoglu, et al.
Published: (2023-02-01)

ANCA-associated vasculitis following the CoronaVac vaccination
by: Yaohui Ma, et al.
Published: (2022-11-01)

Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
by: Samar Samoud, et al.
Published: (2023-08-01)

Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
by: Maëlle Duffey, et al.
Published: (2018-03-01)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
by: Yun Shan Goh, et al.
Published: (2022-01-01)

Immunogenicity and safety of the adult tbe vaccine «tick-e-vac»
by: M. F. Vorovitch, et al.
Published: (2017-04-01)

Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia
by: Cheng Siang Tan, et al.
Published: (2022-09-01)

Construction Of Vac IV : Towards The Development Of DNA Vaccine Candidate Against Tuberculosis [RA644.T7 A284 2008 f rb].
by: Said@Fauzi, Agustine Nengsih
Published: (2007)

Immunogenicity of the CoronaVac vaccine in children: a real-world study
by: Wbeimar Aguilar-Jimenez, et al.
Published: (2024-12-01)

Thrombosis in unvaccinated and Gam-COVID-Vac-vaccinated patients with COVID-19
by: A. G. Moiseeva, et al.
Published: (2022-08-01)

Use of “ARRIAH-AviFluVac” vaccine in turkeys, geese and ducks
by: N. V. Moroz, et al.
Published: (2024-09-01)

Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine
by: Maryam Ameri, et al.
Published: (2022-01-01)

South American monkeys in the development and testing of malarial vaccines - a review
by: William E. Collins
Published: (1992-01-01)

The flagellum in malarial parasites.
by: Sinden, R, et al.
Published: (2010)

MALARIAL RETINOPATHY IN ADULTS
by: Maude, R, et al.
Published: (2011)

Severe malarial anaemia.
by: Casals-Pascual, C, et al.
Published: (2006)

Understanding the Role of Duration of Vaccine Protection with MenAfriVac: Simulating Alternative Vaccination Strategies
by: Andromachi Karachaliou Prasinou, et al.
Published: (2021-02-01)

Editorial: Advances in anti-malarial drug discovery
by: Agam Prasad Singh, et al.
Published: (2023-11-01)

RISE-Vac—Co-Production of Vaccine Education Materials with Persons Living in Prison
by: Femi Laryea-Adekimi, et al.
Published: (2024-04-01)

Longitudinal evaluation of innate immune responses to three doses of CoronaVac vaccine
by: Cheng Cao, et al.
Published: (2023-10-01)

Sperm DNA fragmentation in men vaccinated with Gam-COVID-Vac (Sputnik V)
by: T. M. Sorokina, et al.
Published: (2023-01-01)

Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report
by: Giulia Eduarda Turra Aimi, et al.
Published: (2023-03-01)

The Early-Term Adverse Effects in Healthcare Personnel after CoronaVac Vaccination
by: Mehmet Kabak, et al.
Published: (2022-03-01)

Coronavirus Disease 2019 Frequency After CoronaVac Vaccine: Ascovid Study
by: Burcu Öztürk Şahin, et al.
Published: (2023-01-01)

A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines
by: Delves, M, et al.
Published: (2012)

A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines.
by: Delves, M, et al.
Published: (2012)

VAC067 Peptide Pools
by: Bajer, A
Published: (2024)

VAC067 Safety Data
by: Bajer, A
Published: (2024)

VAC067 TREND Checklist
by: Bajer, A
Published: (2024)

VacA’s Induction of VacA-Containing Vacuoles (VCVs) and Their Immunomodulatory Activities on Human T Cells
by: Ciara Utsch, et al.
Published: (2016-06-01)

MALARIAL RETINOPATHY IN BANGLADESHI ADULTS
by: Abu Sayeed, A, et al.
Published: (2010)